Here are five notes:
1. Spineway boosted its reserve capital by issuing shares with attached warrants for a total of about $1.49 million.
2. China-based TINAVI Medical Technologies paid for the issue of 355,260 new Spineway shares, totaling €1.4 million.
3. TINAVI Medical Technologies holds 9.09 percent of Spineway’s capital, now.
4. TINAVI also holds 5.04 percent of Spineway’s voting rights.
5. Spineway develops implants and instruments for treating vertebral issues.
More articles on devices:
Zimmer Biomet unveils Vault Reconstruction System: 3 quick points
EIT receives investment for international growth, 3-D-printing product development: 5 points
Medtronic, Xtant Medical, Titan Spine & more: 13 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
